Allergic History and Anaphylaxis in COVID-19 Vaccines: A Disproportionality Analysis in the FDA Vaccine Adverse Event Reporting System

被引：0
|
作者：
Giunchi, V. [1 ]
Niero, A. [2 ]
Bartolucci, M. [3 ]
Fusaroli, M. [1 ]
Romio, M. S. [4 ]
Rossi, L. [4 ]
Pulvirenti, L. [4 ]
Savini, D. [4 ]
Sangiorgi, E. [5 ]
Luxi, N.
Trifiro, G. [6 ]
Poluzzi, E. [1 ]
Raschi, E. [1 ]
Sacripanti, C. [4 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy
[2] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy
[3] Univ Bologna, Dept Stat Sci, Bologna, Italy
[4] AUSL Bologna, Dept Pharmaceut, Bologna, Italy
[5] AUSL Ferrara, Dept Pharmaceut, Ferrara, Italy
[6] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy
来源：
DRUG SAFETY | 2022年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P095
引用
收藏
页码：1308 / 1308
页数：1
相关论文
共 50 条
  • [1] Pregnancy safety of COVID-19 vaccines is validated by the Vaccine Adverse Event Reporting System
    Grunebaum, Amos
    Bornstein, Eran
    Gulersen, Moti
    Chervenak, Frank A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S694 - S695
  • [2] Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
    Frontera, Jennifer A.
    Tamborska, Arina A.
    Doheim, Mohamed F.
    Garcia-Azorin, David
    Gezegen, Hasim
    Guekht, Alla
    Khan, Abdul Hanif Khan Yusof
    Santacatterina, Michele
    Sejvar, James
    Thakur, Kiran T.
    Westenberg, Erica
    Winkler, Andrea S.
    Beghi, Ettore
    [J]. ANNALS OF NEUROLOGY, 2022, 91 (06) : 756 - 771
  • [3] Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System
    Nikitina, Victoria
    Laurini, Greta Santi
    Montanaro, Nicola
    Motola, Domenico
    [J]. ACTA PAEDIATRICA, 2023, 112 (11) : 2426 - 2433
  • [4] A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
    Zou, Wenbin
    Yang, Han
    Xi, Yu
    Zeng, Chenxi
    Chen, Wei
    Fu, Xiangning
    [J]. HELIYON, 2024, 10 (17)
  • [5] ADVERSE EVENTS ASSOCIATED WITH COVID-19 AND SEASONAL INFLUENZA VACCINES: A RETROSPECTIVE AND DESCRIPTIVE ANALYSIS OF CDC/FDA VACCINE ADVERSE EVENT REPORTING SYSTEM (VAERS) REPORTS
    Alqahtani, Z.
    Guo, J. J.
    Wigle, P. R.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S466 - S466
  • [6] A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
    Pan, Yunyan
    Wang, Yu
    Zheng, Yifan
    Chen, Jie
    Li, Jia
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
    Pistor, Maximilian
    Hoepner, Robert
    Hoepner, Andreas G. F.
    Lin, Yanan
    Jung, Simon
    Bassetti, Claudio L.
    Chan, Andrew
    Salmen, Anke
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
  • [8] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Zou, Shu-peng
    Yang, Hai-yun
    Ouyang, Meng-ling
    Cheng, Qian
    Shi, Xuan
    Sun, Ming-hui
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [9] Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
    Shu, Yamin
    Ding, Yiling
    Liu, Lulu
    Zhang, Qilin
    [J]. CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2705 - 2716
  • [10] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    [J]. BMC Pharmacology and Toxicology, 24
12345